Rafferty Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,810
Closed -$235K 1123
2025
Q4
$235K Buy
3,810
+485
+15% +$29.7K ﹤0.01% 1053
2025
Q3
$207K Buy
3,325
+533
+19% +$37.1K ﹤0.01% 1068
2025
Q2
$223K Sell
2,792
-919
-25% -$76.9K ﹤0.01% 1033
2025
Q1
$319K Buy
3,711
+513
+16% +$42.1K ﹤0.01% 948
2024
Q4
$250K Sell
3,198
-636
-17% -$49.4K ﹤0.01% 1055
2024
Q3
$276K Buy
3,834
+166
+5% +$11.8K ﹤0.01% 1049
2024
Q2
$253K Buy
+3,668
New +$249K ﹤0.01% 1090
2022
Q3
Sell
-3,580
Closed -$211K 1220
2022
Q2
$211K Buy
+3,580
New +$197K ﹤0.01% 1034
2022
Q1
Sell
-3,364
Closed -$204K 1302
2021
Q4
$204K Sell
3,364
-593
-15% -$35.2K ﹤0.01% 1223
2021
Q3
$222K Buy
+3,957
New +$217K ﹤0.01% 1179
2019
Q3
Sell
-8,811
Closed -$279K 835
2019
Q2
$279K Buy
+8,811
New +$262K ﹤0.01% 756

Other funds holding PBH

Rafferty Asset Management's PBH Position: Q1 2026 in Review

Rafferty Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 3,810 shares — an estimated $235K sold.

Rafferty Asset Management first reported a position in PBH in Q2 2019 and held it in 11 quarters. The position peaked at $319K in Q1 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Rafferty Asset Management reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 3,810 Prestige Consumer Healthcare shares in Q1 2026, an estimated $235K.
  • Rafferty Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2019 and held it in 11 quarters.
  • Rafferty Asset Management's Prestige Consumer Healthcare position peaked at $319K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.